Location: Home> Products> Star Products
Click to return to the list
Common name: Pegylated recombinant human granulocyte stimulating factor injection
English name: PEGylated Recombinant Human Granulocyte Colony
Approval number: National Medicine Standard S20110014
Specification: 3.0mg (1.0ml) / piece
Indications: When patients with non-myeloid malignancies receive antitumor therapy, when clinically significant febrile neutropenic myelosuppression may occur, use this product to reduce the incidence of infection caused by febrile neutropenia rate. This product is not used for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation.